Department of Gynecology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medicine College, Hangzhou, 310014, China.
Department of Gynecology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310014, China.
Exp Cell Res. 2020 Oct 15;395(2):112235. doi: 10.1016/j.yexcr.2020.112235. Epub 2020 Aug 14.
This study was aimed to identify an accurate gene expression signature to predict overall survival (OS) in patients with ovarian cancer (OC).
Expression data and corresponding clinical information were obtained from two independent databases: the Cancer Genome Atlas (TCGA) dataset and International Cancer Genome Consortium (ICGC) dataset. Multiple analysis methods including univariate and multivariate COX regression analysis and Least Absolute Shrinkage and Selection Operator (LASSO) regression analysis were utilized to build the signature. Receiver operating characteristic (ROC) and Kaplan-Meier (KM) survival analyses were used to assess the predictive accuracy of this gene signature.
A novel 10-gene signature with high predictive accuracy for OS in OC patients was constructed and validated in the training and validation set. Based on the results of univariate and multivariate analyses, the presence of risk Score was identified as an independent prognostic factor for survival of OC patients. Moreover, we developed a nomogram model based on these 10 genes in the signature, which also displayed a favorable predictive efficacy for prognosis in OC.
Our results identified a robust 10-gene signature for OC prognosis prediction, which might be applied to assist clinical decision-making and individualized treatment.
本研究旨在确定一种准确的基因表达特征,以预测卵巢癌(OC)患者的总生存期(OS)。
从两个独立的数据库:癌症基因组图谱(TCGA)数据集和国际癌症基因组联盟(ICGC)数据集获取表达数据和相应的临床信息。利用单变量和多变量 COX 回归分析以及最小绝对值收缩和选择算子(LASSO)回归分析等多种分析方法构建特征。使用接收者操作特征(ROC)和 Kaplan-Meier(KM)生存分析来评估该基因特征的预测准确性。
构建并验证了一个用于 OC 患者 OS 预测的具有高预测准确性的新型 10 基因特征。基于单变量和多变量分析的结果,风险评分的存在被确定为 OC 患者生存的独立预后因素。此外,我们基于特征中的这 10 个基因开发了一个列线图模型,该模型也显示出对 OC 预后预测的良好预测效果。
我们的结果确定了一种用于 OC 预后预测的稳健的 10 基因特征,可能适用于辅助临床决策和个体化治疗。